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Lumbar disc herniation (LDH), degeneration and herniation of the nucleus pulposus of the intervertebral disc (IVD) of
the lumbar spine, is one of the most common musculoskeletal diseases. Its etiology and pathogenesis, however, remain
unclear. Type XI collagen is important for cartilage collagen formation and for organization of the extracellular matrix.
We identified an association between one of the type XI collagen genes, COL11A1, and LDH in Japanese populations.
COL11A1, which encodes the a1 chain of type XI collagen, was highly expressed in IVD, but its expression was decreased
in the IVD of patients with LDH. The expression level was inversely correlated with the severity of disc degeneration. A
single-nucleotide polymorphism (c.4603CrT [rs1676486]) had the most significant association with LDH (Pp 3.3#
), and the transcript containing the disease-associated allele was decreased because of its decreased stability. These5610
observations indicate that type XI collagen is critical for IVD metabolism and that its decrease is related to LDH.
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Lumbar disc herniation (LDH), degeneration and herni-
ation of the nucleus pulposus of intervertebral disc (IVD)
of the lumbar spine, is one of the most common mus-
culoskeletal diseases.1–3 Its etiology and pathogenesis,
however, remain unclear. Genetic factors have been im-
plicated in the etiology of lumbar disc degeneration.4,5 Ge-
netic abnormalities of the extracellular matrix (ECM) are
implicated in disc degeneration and LDH. Phenotypes of
transgenic mice and human mutations underscore the
candidacy of ECM genes as susceptibility genes for LDH.6,7
Several researchers have reported the association of ECM
protein genes, including genes for type IX collagen8,9 and
aggrecan,10 with lumbar disc disease (LDD). We reported
elsewhere that cartilage intermediate layer protein and as-
porin—ECM proteins highly expressed in IVD, as well as
articular cartilage—are implicated in LDD.11,12
Type XI collagen is a cartilage-specific ECM protein im-
portant for cartilage collagen fibril formation and for ECM
organization.13–16 Type XI collagen is composed of three
a-chains, a1(XI), a2(XI), and a3(II), which are encoded
by COL11A1, COL11A2, and COL2A1, respectively. The
three chains fold into triple-helical heterotrimers to form
procollagen, which is secreted into the ECM, where it par-
ticipates in fibril formation with other cartilage-specific
collagens, type II and IX collagens.13 Type XI collagen reg-
ulates the diameter of cartilage collagen fibrils. Its N-ter-
minal noncollagenous region limits the appositional lat-
eral growth of the fibril by blocking further accretion of
type II collagen.14,15 Chondrodysplasia in mouse (cho) is
an autosomal recessive disorder due to a frame-shift mu-
tation of COL11A1.16 The collagen fibrils of cho mice are
much thicker than normal.16,17 Thus, type XI collagen has
a critical role in the organization of the supramolecular
architecture of cartilage collagen.
Type XI collagen is present in IVD, both in the annulus
fibrosus and nucleus pulposus,18 but its significance in
LDH is not known. Type XI collagen is a quantitatively
minor component of cartilage collagen fibrils, but it is
essential for the interaction between proteoglycan (PG)
aggregates and collagens. It binds with high affinity to PG,
which is important in vivo for anchoring cartilage PG to
the collagen fibrillar network.19 Mutations in type XI col-
lagen cause various types of chondrodysplasias in human,
including Stickler syndrome type II (MIM #604841), Mar-
shall syndrome (MIM #154780), and oto-spondylo-mega-
epiphyseal dysplasia (MIM #215150). These disorders are
collectively termed “type XI collagenopathies,”20 and all
are complicated by abnormalities of the spine, including
narrowing of the IVD. In particular, patients with Stickler
syndrome have spondylar abnormalities and Schmorl’s
node (disc herniation into the vertebral body).21 These
human mutations are in vivo evidence that type XI col-
lagen is critical for IVD integrity; thus, the type XI collagen
genes are good candidates for the gene that causes LDH.
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Table 1. Clinical Characteristics of Subjects
Screening
and Group
No. of
Subjects
Age
(years)
Male
(%) BMIaMean  SD Range
1st:
Case:
LDDb 188 26.5  10.4 13–74 40.0 21.0
LDH only 130 25.5  6.9 13–66 54.0 21.1
Control 179 58.7  11.7 23–81 6.0 23.0
2ndc:
Case 359 41.4  14.6 15–77 62.4 23.1
Control 286 69.6  9.2 38–87 58.4 24.3
3rdc:
Case 334 41.8  15.1 11–83 61.3 23.4
Control 376 53.9  9.7 13–86 47.6 22.2
a BMI calculated as body weight in kilograms divided by the square
of height in meters.
b Includes disc degeneration only and LDH.
c Case group in the 2nd and 3rd screenings has LDH only.
Table 2. Association between LDH and c.4603CrT (rs1676486) in COL11A1
Screening
and Case Group
No. of Cases
with Genotype
Total
No. of
Cases
No. of Controls
with Genotype
Total
No. of
Controls
T Allele
Frequency
P OR (95% CI)CC CT TT CC CT TT Case Control
1st:
LDD a 85 86 17 188 99 67 13 179 .31 .26 .076 1.34 (.97–1.84)
LDH only 55 60 15 130 99 67 13 179 .34 .26 .020 1.51 (1.07–2.14)
2nd:
LDH only 149 163 47 359 154 108 21 283 .35 .26 .00038 1.55 (1.21–1.97)
a Includes disc degeneration only and LDH.
Here, we present evidence that COL11A1, one of the
type XI collagen genes, contributes to the genetic risk of
LDH in Japanese. We have observed significant association
between LDH and a functional SNP in COL11A1 in in-
dependent Japanese populations. COL11A1 was highly ex-
pressed in IVD, but its expression was decreased in the
IVD of patients with LDH. COL11A1 expression level was
inversely correlated with the severity of disc degeneration
in patients with LDH, and the transcript containing the
disease-associated allele of the SNP was decreased.
Material and Methods
Study Population
All subjects were Japanese who were living in the middle part of
the Honshyu island in Japan (table 1). They visited the partici-
pating hospitals and received medical examinations. For the ini-
tial screening, we recruited 188 case patients with LDD and 179
control subjects. The mean ages of the case and control groups
were 26.5 and 58.7 years, respectively. The case group included
58 patients who had no herniation (disc degeneration only) and
130 patients with LDH. The mean age of the LDH case patients
was 25.5 years. For the second screening (replication study), we
recruited 359 patients with LDH and 286 control subjects. The
mean ages of the case and control groups were 41.4 and 69.6
years, respectively. For the third screening, we recruited 334 pa-
tients with LDH and 376 control subjects. The mean ages of the
case and control groups were 41.8 and 53.9 years, respectively.
Subjects for the initial, second, and third screenings were re-
cruited at the participating hospitals in the Toyama, Tokyo, and
Kyoto areas, respectively. All LDH case patients had unilateral
pain radiating from the back along the femoral or sciatic nerve
to the corresponding dermatome of the nerve root with duration
of 13 mo. Radiographic examination, including functional four-
direction images and magnetic resonance imaging (MRI) (sagittal
and axial images obtained with a 1.5-T imaging system), revealed
positive findings indicating disc herniation. The degree of disc
degeneration was evaluated by MRI and was scored according to
Schneiderman’s classification.22 Of the affected individuals, 787
case patients underwent surgical treatment, and the other indi-
viduals with LDH were treated conservatively. All were followed
up for 11 year. We excluded from the study individuals with spinal
canal stenosis, spondylolisthesis, spondylosis, synovial cysts, spi-
nal tumor, and trauma. We also excluded those who had occu-
pational and/or habitual risk factors, such as heavy manual la-
borers, occupational drivers, and heavy smokers. We obtained
informed consent from each subject, as approved by the ethical
committees at the SNP Research Center of RIKEN and the par-
ticipating hospitals.
Genotyping
We selected sequence variations of the type XI collagen genes
(COL11A1, COL11A2, and COL2A1) for the first screening from
the International HapMap Project database and JSNP Database.
The SNPs covered 190% of the alleles with an value 0.8. We2r
identified additional sequence variations in COL11A1 by direct
sequencing of a 230-kb region of DNA from 24 case patients. We
extracted genomic DNA for genotyping from peripheral blood
leukocytes of the subjects and genotyped SNPs as described
elsewhere.11,12
Haplotype Structure and Statistical Analyses
We estimated haplotype frequencies, using the expectation-max-
imization algorithm and pairwise linkage-disequilibrium index
(D′ and D in 465 control individuals, as described elsewhere).23 x2
tests were used to compare cases with controls for allelic and
genotypic frequencies; the odds ratio (OR) and its 95% CI were
calculated. We used a permutation test to adjust significance in
the analysis of association between the COL11A1 SNPs and LDH.24
We performed 107 permutations of the cases and the controls.
Bonferroni correction was applied when significance was adjusted
for the number of SNPs genotyped. MRI data, real-time PCR data,
and mRNA stability data were tested using Student’s t test.
Analysis of COL11A1 Expression
We extracted and purified total RNAs and synthesized randomly
primed cDNAs, using Multiscribe reverse transcriptase (PE Ap-
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Table 3. Polymorphisms in COL11A1 and Their Association with LDH
Location in COL11A1
and Nucleotide
Sequence Change
Amino
Acid
Change dbSNP
No. in the Three
Genotype Groupsa
Allelic
Frequency Pb
OR (95% CI)cCase Control Case Control Allele Genotyped
IVS1:
9284TrC … rs1415359 423/63/1 422/42/1 .07 .05 .068 .16 .69 (.47–1.03)
IVS6:
82274ArC … … 437/49/1 424/38/1 .05 .04 .35 .61 .82 (.53–1.25)
IVS10:
90221GrA … rs945748 426/62/1 414/48/1 .07 .05 .29 .54 .82 (.56–1.19)
IVS11:
90406ArG … rs3767272 396/76/3 401/55/0 .09 .06 .032 .049 1.47 (1.03–2.10)
IVS20:
104122ArT … rs2622877 438/47/2 400/46/0 .05 .05 .94 .38 .98 (.65–1.48)
IVS26:
111262TrC … rs2786125 428/49/1 429/33/1 .05 .04 .11 .24 .70 (.45–1.08)
IVS41:
146354TrC … rs1012282 425/62/1 415/47/1 .07 .05 .24 .47 1.26 (.86–1.84)
IVS42:
165864ArC … rs1841838 381/104/3 374/84/6 .11 .1 .52 .27 1.10 (.82–1.47)
IVS44:
169351ArG … rs2126643 378/100/3 373/79/6 .11 .1 .44 .23 1.12 (.84–1.51)
172702CrG … rs3767273 382/103/3 372/84/4 .11 .1 .41 .5 .88 (.66–1.19)
IVS50:
192606GrA … rs4908273 231/211/43 271/167/23 .31 .23 .00023 .001 1.47 (1.20–1.80)
Exon 52:
193817(c.3968)TrC L1323P rs3753841 193/230/65 238/187/38 .37 .28 .000081 .00041 1.47 (1.21–1.79)
IVS52:
194187TrC … … 218/214/48 258/178/26 .32 .25 .00038 .0016 .69 (.57–0.85)
IVS54:
200918ArG … rs3767274 399/73/4 367/86/5 .09 .1 .15 .34 .79 (.58–1.08)
206255GrT … rs3767275 457/30/0 442/15/1 .03 .02 .088 .068 .60 (.33–1.09)
208970TrA … rs1676500 443/45/1 425/33/1 .05 .04 .29 .53 1.27 (.81–1.99)
IVS58:
218282CrG … … 431/46/1 430/32/1 .05 .04 .15 .32 .72 (.46–1.13)
Exon 62:
219597(c.4603)CrT P1535S rs1676486 204/223/62 252/177/33 .35 .26 .000015 .000099 1.54 (1.27–1.88)
Exon 63:
221284(c.4770)CrT I1590I rs2229783 169/236/83 214/201/47 .41 .32 .000028 .00017 1.49 (1.24–1.80)
IVS63:
221659GrA … rs1463048 169/235/83 212/199/50 .41 .32 .000081 .00047 1.46 (1.21–1.76)
IVS65:
225275TrA … rs3753844 207/223/55 239/186/33 .34 .28 .0014 .0056 1.38 (1.13–1.68)
Exon 67 (3′ UTR):
230265CrT … rs1031820 443/45/1 430/33/1 .05 .04 .27 .5 .78 (.50–1.21)
230461ArG … … 439/45/1 429/33/0 .05 .04 .17 .3 .73 (.46–1.15)
NOTE.—The cDNA (accession number NM001854.2) and genomic DNA (accession numbers AC093150.4, AL627203.7, and AC099567.2) sequences
of COL11A1 are based on data from GenBank. The A of the ATG translation initiation codon in the reference sequence corresponds to
position 1.
a Homozygote of the major allele/heterozygote/homozygote of the minor allele.
b By the x2 test.
c Calculated for the alleles.
d Calculated for the homozygotes of the major allele versus the heterozygotes and the homozygotes of the minor allele.
Table 4. Correlation between Age and Genotype
at c.4603CrT (rs1676486) in COL11A1
Population
Mean  SD Age (in years) for Genotype
PaCC CT TT
Case 36.8  15.0 36.9  14.5 36.8  14.5 .58
Control 64.8  12.1 63.9  11.1 63.1  13.1 .54
a P value was calculated using the Kruskal-Wallis test.
plied Biosystems). We performed quantitative real-time PCR using
the ABI PRISM 7700 (Applied Biosystems) and QuantiTect
SYBR Green PCR (QIAGEN) according to the manufacturer’s
instructions.
RNA Stability Assay
We amplified by PCR ∼1,700-bp of COL11A1 cDNA that con-
tained the entire ORF. We cloned the COL11A1 cDNA containing
the associated SNP c.4603CrT into pCR-Blunt II-TOPO (Invitro-
gen) and confirmed the sequence of the inserts. Vectors were
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Table 5. Genotype at c.4603CrT (rs1676486) in COL11A1,
Stratified by Sex
Measure
Male Female
Case Control Total Case Control Total
No. of subjects:
All 298 177 475 191 285 476
CC 116 98 214 88 154 242
CT 144 65 209 79 112 191
TT 38 14 52 24 19 43
T allele frequency (%) .37 .26 .33 .33 .26 .29
P valuea … … .00074 … … .021
a P value for allelic difference between the patients with LDH and the
control groups for each sex, by the x2 test.
Figure 1. Case-control association study and linkage-disequilib-
rium mapping. a, Association of COL11A1 with LDH. The log10
transformation of the corrected P value (allele 1 vs. allele 2) was
plotted on the Y-axis. The asterisk (*) indicates c.4603CrT. b,
Pairwise linkage disequilibrium between SNPs in and around
COL11A1 measured by D′ and D in 465 controls. The COL11A1 region
is divided into two linkage-disequilibrium blocks.
Table 6. Haplotype Association
Analysis of COL11A1 with LDH
Haplotype
Frequency
PaCase Control
H1 .527 .616 .000154
H2 .302 .222 .000150
H3 .038 .039 .90
H4 .041 .037 .63
H5 .045 .034 .27
H6 .014 .014 .91
H7 .011 .008 .50
NOTE.—Results are for the haplotypes
of block 2 that contained the suscepti-
bility SNP, c.4603CrT.
a By the x2 test.
digested using HindIII, and COL11A1 mRNAs were transcribed
using RiboMax Large Scale RNA Production System-T7 (Promega)
and were purified by SV Total RNA Isolation System (Promega).
The whole-cell extract was prepared by washing OUMS-27 cells
in PBS and resuspending them in an extraction buffer. After in-
cubation on ice for 30 min and microcentrifugation at 4C, we
transferred supernatants to new tubes and stored them at 80C
until use. We mixed and incubated each 5 mg of synthesized RNA
and the diluted (1:1,000) whole-cell extract at room temperature
for the tested time (5 or 10 min). We stopped the reaction with
addition of a formamide dye. The samples were then heated at
95C for 5 min and were placed on ice immediately. We detected
COL11A1 mRNAs of the samples by northern-blot analysis and
quantified their signal intensities, using the Esper-Scanner (Ep-
son) and Adobe Photoshop 6.0.
Immunohistochemistry for Type XI Collagen
We processed and embedded tissue samples in paraffin by the
AMeX method. We predigested the tissue sections with 500 U/
ml of testicular hyaluronidase (Sigma) for 30 min at 37C. For
immunofluorescent visualization, we blocked nonspecific label-
ing with blocking reagent (DakoCytomation) for 10 min at room
temperature and then incubated the sections with the rabbit poly-
clonal antibody against bovine type XI collagen (1:500) at 4C
overnight. For the staining of the negative control, we applied
nonimmune rabbit IgG (DakoCytomation) to the section instead
of primary antibody. After washing them with Tris-buffered sa-
line, we incubated the sections with secondary antibody conju-
gated to horseradish peroxidase–labeled polymer (Envision
[DakoCytomation]) for 30 min at room temperature. We visual-
ized the immunoreactive products using a diaminobenzidine re-
agent and counterstained them with hematoxylin.
Results
We first examined the association of the type XI collagen
genes (COL11A1, COL11A2, and COL2A1) with LDD,
which included patients with and without LDH. We tested
tag SNPs that were selected from the JSNP Database and
the International HapMap Project database. A comparison
of 188 LDD cases and 179 controls revealed no association
with any of the SNPs; however, there was a significant
association with COL11A1 when cases were stratified on
the basis of the presence or absence of LDH (table 2). In
a comparison of 130 patients with LDH with 179 controls,
one SNP (c.4603CrT [rs1676486]) had a significant asso-
ciation. To confirm the association, we examined another
359 LDH cases and 286 controls for the COL11A1 SNP.
Again, we identified the significant association between
the SNP and LDH (table 2). Adjusted was ob-Pp .00030
tained by 107 permutations
To identify the disease-causing sequence variation, we
examined sequence variations in COL11A1 exons and
their flanking regions from a public database and by re-
sequencing 24 patients with LDH. A total of 23 sequence
variations were identified and were tested for association.
SNP c.4603CrT had the most significant association (table
3), which remained significant after Bonferroni correction
for multiple testing. We examined whether confounding
effects, such as age and sex, affect the associations with
LDH and found no relationship between the genotype and
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Table 7. Association between Genotype at c.4603CrT
(rs1676486) in COL11A1 and LDH in the Japanese
Population
Group
No. with
Genotype
Allelic
Frequency P
OR
(95% CI)CC CT TT
Case 360 367 96 .34 .0000033 1.42
(1.23–1.65)
Control 453 325 60 .265
Figure 2. Difference in transcription and stability of COL11A1 mRNA containing the LDH-associated SNP. a, Relative cDNA expression
of c.4603CrT evaluated by real-time PCR. Data represent the ratios of cDNA to genomic DNA, and expression of the C allele is converted
to 1 (an asterisk [*] indicates , by Student’s t test). Data represent the mean  SD in triplicate assays. b, Sequential changeP ! .05
of COL11A1 mRNA analyzed by northern blotting. “4603C” and “4603T” indicate COL11A1 mRNA produced by in vitro transcription with
c.4603C and c.4603T, respectively. c, Rate of degradation of the transcripts. Diamonds indicate the transcript with c.4603C; squares
indicate the transcript with c.4603T. The difference of the rate of degradation was significant at both 5 min and 10 min after the
reaction (an asterisk (*) indicates , by Student’s t test). Data represent the mean  SD in triplicate assays.P ! .05
these factors (table 4). The association was positive in both
sexes (table 5).
Using the 20 SNPs in and around COL11A1 that had a
minor-allele frequency 110%, we analyzed the linkage-
disequilibrium structure of the region and found highly
structured linkage-disequilibrium blocks (fig. 1). COL11A1
was covered by two blocks, and the SNP with a significant
association (c.4603CrT) was contained in block 2. We fur-
ther analyzed the haplotype structure of block 2 and iden-
tified seven haplotypes with frequencies 10.01 that cov-
ered 197% of both the case and control groups (table 6).
The association was weaker than that of c.4603CrT alone,
suggesting the absence of a hidden causal SNP. We further
examined the association of the SNP, using an additional
334 patients with LDH and 376 controls. Our findings of
the association between this SNP and LDH were replicated
( ; OR 1.27 [95% CI 1.01–1.59]. Therefore, this SNPPp .044
is strongly associated with LDH (combined Pp 3.3#
in allelic frequency) (table 7).610
To clarify the functional impact of c.4603CrT, we quan-
tified the allelic difference of the mRNA expression by real-
time RT-PCR. The expression level of the susceptibility
allele c.4603T was significantly lower than that of the
c.4603C allele (fig. 2a). We hypothesized that this SNP
affects COL11A1 transcription by altering mRNA stability
and examined the stability of COL11A1 mRNA containing
the SNP. We mixed mRNAs produced by in vitro tran-
scription with cell lysate and assessed mRNA degradation
by endogenous components of the cells, using northern-
blot analysis. The transcript containing the susceptible al-
lele degraded faster (fig. 2b and 2c).
To gain insight into the role of type XI collagen in LDH,
we examined COL11A1 expression in tissues and cells by
quantitative real-time PCR. COL11A1 mRNA was predom-
inantly expressed in IVD (fig. 3a). We investigated the
correlation between the COL11A1 mRNA expression level
and a variety of LDH phenotypes and found that severity
of disc degeneration evaluated by MRI was inversely cor-
related with COL11A1 expression in IVDs of patients with
LDH (fig. 3b). We further analyzed the expression and lo-
calization of type XI collagen in IVD by immunohisto-
chemistry. Normal discs had a highly uniform ECM struc-
ture, with intense immunostaining of type XI collagen in
the nucleus pulposus cells and ECM (fig. 3c). In degen-
erative discs, however, we observed weak immunostaining
of type XI collagen around the nucleus pulposus cells (fig.
3d). These findings implicate a decrease of type XI collagen
in the pathogenesis of LDH.
Discussion
Through a case-control association study focusing on type
XI collagen, we identified COL11A1 as a susceptibility
gene for LDH. COL11A1 mRNA was substantially ex-
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Figure 3. Type XI collagen expression in human. a, COL11A1 expression in different tissues. COL11A1 mRNA was predominantly expressed
in IVD. b, Inverse correlation between COL11A1 expression and severity of degeneration of IVD in patients with LDH (an asterisk [*]
indicates , by Student’s t test). The degree of disc degeneration is evaluated by MRI and is scored according to the classificationP ! .05
of Schneiderman. c and d, Immunostaining of type XI collagen in IVDs from an unaffected individual (c) and a patient with LDH
(Schneiderman’s grade 3) (d). Ubiquitous and intense staining was found in the normal disc. In contrast, the staining was found only
in and around the territorial matrices of clustered cells in the degenerative disc. The white scale bar indicates 50 nm.
pressed in IVD, and the expression in patients with LDH
was decreased according to the severity of degeneration.
Our findings further indicate that the susceptibility SNP
produces unstable COL11A1 transcripts. A few cis-ele-
ments have been implicated in mRNA stabilization.25 The
4856–4865 nucleotides (caaaaaatct) in COL11A1 mRNA
closely match the consensus for a mRNA stability motif,
“g/tanaaaag/tcc/t.”26 The sequence variation might affect
the mRNA stability motif and disrupt the cis-element crit-
ical for mRNA stability, although they are 1200 bp apart.
Alternatively, the sequence variation might induce a con-
formational change in the mRNA that would decrease
mRNA stability or increase the sensitivity to RNase. The
decrease of the COL11A1 transcript would lead to a de-
crease in type XI collagen in the ECM of IVD.
IVD has a highly structured ECM to resist mechanical
forces. The highly oriented network of the fibrillar colla-
gens offers tensile strength,27,28 and highly hydrated ag-
gregating PG resists comprehensive forces. They form a
mesh suited to holding water molecules, which further
increases their ability to withstand mechanical forces.
Therefore, the structural integrity of ECM and the phys-
iologic balance of its components are critical to IVD func-
tion. Perturbation of ECM metabolism would increase the
mechanical load of the IVD, leading to its degeneration.
The reduction in type XI collagen, the critical organizer
of ECM, ultimately causes disintegration of ECM and
hence IVD degeneration, although it could occur as a sec-
ondary event of LDH. The present study underscores the
importance of ECM proteins in the pathogenesis of com-
mon bone and joint diseases, including LDH. Our results
should lead to a better understanding of the pathogenic
mechanisms of LDH and suggest promising targets for a
novel treatment strategy for LDH.
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